Abstract
Aim: The present study aims at explaining the epidemic situation in India for COVID-19 and forecasting the expected rise in the positive cases in India.
Objective: This study will be useful for Government authorities and Medical Practitioners in assessing the trends for India and preparing a combat plan with stringent measures. This research would also be useful in predicting outbreak numbers with greater precision for people involved in exploring this deadly disease.
Methods: We used the Support Vector Machine (SVM) to forecast and analyze the COVID-19 situations to predict future trends. On definite trail and model training, it was observed that the number of COVID cases will increase for the next four days.
Results: The SVM model predicted accurate results. The prediction accuracy seems to best fit and indicates the cases to rise in the next coming days. Confirmed cases and the SVM predictions are close to each other, thus proving the accuracy of the SVM predictions. It was inferred that the numbers of COVID-19 instances will rise if the same trend is followed.
Conclusion: The COVID-19 outbreak is exacerbated by secondary hospital transmission. Testing, particularly of those coming in with respiratory symptoms, is essential to isolate those in hospitals. A two-stage, pre-emptive testing is recommended in symptomatic older people immediately to reduce mortality. Immediate and on-going serological surveys are required to track the epidemic level. We are flying blind at the moment. The demand for the ventilators would be 1 million. The current supply in India is projected to range from 30 K to 50 K (the US has 160 K and is still running short). Health staff involved in treating COVID-19 patients also have to shield themselves using personal protection (i.e., masks and gowns) to save themselves from being infected. Thus, SVM model predictions will give a better insight into the growth of COVID-19 cases and, therefore, will allow the government of India to take adequate measures to restrain the issue at the earliest.
Keywords: COVID-19, SVM, stringent action, modelling, forecast, India.
Graphical Abstract
The Natural Products Journal
Title:Predicting the Cumulative Number of Cases of the COVID-19 Epidemic in India from Early Data
Volume: 11 Issue: 5
Author(s): Amit Kumar Thakur*, Rajesh Singh, Anita Gehlot, Prabin Kumar Das and Bishwajyoti Roy
Affiliation:
- Department of Mechanical Engineering, Lovely Professional University, Phagwara, Punjab,India
Keywords: COVID-19, SVM, stringent action, modelling, forecast, India.
Abstract:
Aim: The present study aims at explaining the epidemic situation in India for COVID-19 and forecasting the expected rise in the positive cases in India.
Objective: This study will be useful for Government authorities and Medical Practitioners in assessing the trends for India and preparing a combat plan with stringent measures. This research would also be useful in predicting outbreak numbers with greater precision for people involved in exploring this deadly disease.
Methods: We used the Support Vector Machine (SVM) to forecast and analyze the COVID-19 situations to predict future trends. On definite trail and model training, it was observed that the number of COVID cases will increase for the next four days.
Results: The SVM model predicted accurate results. The prediction accuracy seems to best fit and indicates the cases to rise in the next coming days. Confirmed cases and the SVM predictions are close to each other, thus proving the accuracy of the SVM predictions. It was inferred that the numbers of COVID-19 instances will rise if the same trend is followed.
Conclusion: The COVID-19 outbreak is exacerbated by secondary hospital transmission. Testing, particularly of those coming in with respiratory symptoms, is essential to isolate those in hospitals. A two-stage, pre-emptive testing is recommended in symptomatic older people immediately to reduce mortality. Immediate and on-going serological surveys are required to track the epidemic level. We are flying blind at the moment. The demand for the ventilators would be 1 million. The current supply in India is projected to range from 30 K to 50 K (the US has 160 K and is still running short). Health staff involved in treating COVID-19 patients also have to shield themselves using personal protection (i.e., masks and gowns) to save themselves from being infected. Thus, SVM model predictions will give a better insight into the growth of COVID-19 cases and, therefore, will allow the government of India to take adequate measures to restrain the issue at the earliest.
Export Options
About this article
Cite this article as:
Thakur Kumar Amit *, Singh Rajesh, Gehlot Anita , Das Kumar Prabin and Roy Bishwajyoti , Predicting the Cumulative Number of Cases of the COVID-19 Epidemic in India from Early Data, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200813154206
DOI https://dx.doi.org/10.2174/2210315510999200813154206 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Death Due to COVID-19 in an Infant with Combined Immunodeficiencies
Endocrine, Metabolic & Immune Disorders - Drug Targets Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II)
Current Pharmaceutical Design COVID-19: The Unprecedented Malady- A Holistic Review
Coronaviruses Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An <i>In Silico</i> Study
Medicinal Chemistry Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Current Signal Transduction Therapy Quantification of Glycyrrhetic Acid in Human Plasma by LC–MS/MS: Application to a Pharmacokinetic Study
Current Pharmaceutical Analysis Forecasting of Covid-19 Cases Using Machine Learning Approach
Current Respiratory Medicine Reviews Ligand and Structure-based Virtual Screening of Lamiaceae Diterpenes with Potential Activity against a Novel Coronavirus (2019-nCoV)
Current Topics in Medicinal Chemistry Withdrawal Notice: An Efficient Approach for Detection and Verification of Infected Cases of Covid-19 Virus through Block Chain: A Survey
International Journal of Sensors, Wireless Communications and Control A Comparative Study of SARS, MERS with COVID-19
Coronaviruses Angiotensin (1-7) and other Angiotensin Peptides
Current Pharmaceutical Design Covid-19: An Update on Clinical Features, Diagnosis, and Treatment Strategies
Coronaviruses Role of Cations in the Interaction of Pradimicins with HIV-1 Envelope gp120
Current Topics in Medicinal Chemistry Withdrawal Notice: Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts’ Cell
Current Pharmaceutical Design Chest Radiograph (CXR) Manifestations of the Novel Coronavirus Disease 2019 (COVID-19): A Mini-review
Current Medical Imaging Molecular Insights into Resveratrol and Its Analogs as SARS-CoV-2 (COVID-19) Protease Inhibitors
Coronaviruses Covid-19: Urgent Call to Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?
Current HIV Research COVID-19 Pandemic: An Overview of its Origin, Current Status, and Ongoing Clinical Trials
Coronaviruses Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry